Cart
sales@molnova.com
BI-409306
CAS No. 1189767-28-9
BI-409306 ( —— )
Catalog No. M21934 CAS No. 1189767-28-9
BI-409306 is a potent and selective inhibitor of PDE9A (IC50 of 52 nM),and can be used in the research of memory.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 178 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 494 | In Stock |
|
| 200MG | 709 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBI-409306
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI-409306 is a potent and selective inhibitor of PDE9A (IC50 of 52 nM),and can be used in the research of memory.
-
DescriptionBI-409306 is a potent and selective inhibitor of PDE9A (IC50 of 52 nM),and can be used in the research of memory.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE9A
-
Research AreaNervous system
-
IndicationAlzheimer Disease
Chemical Information
-
CAS Number1189767-28-9
-
Formula Weight311.34
-
Molecular FormulaC16H17N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:22 mg/ml(50.06 mM)
-
SMILESO=c1[nH]c(Cc2ccccn2)nc2n(ncc12)C1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cornelia Dorner-Ciossek, R. Giovannini, Holger Rosenbrock. BI 409306, A NOVEL PHOSPHODIESTERASE 9A INHIBITOR, PART I: POTENCY, SELECTIVITY AND IN-VITRO FUNCTIONAL CHARACTERIZATION ON SYNAPTIC PLASTICITY[C]// International Congress on Schizophrenia Research. 2015.
molnova catalog
related products
-
Triflusal
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
-
Dypyridamole
Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.
-
Carbazeran
Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
